412 results on '"Tisdale, M J"'
Search Results
2. Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
3. Role of the dsRNA-dependent protein kinase (PKR) in the attenuation of protein loss from muscle by insulin and insulin-like growth factor-I (IGF-I)
4. Induction of apoptosis by a cachectic-factor in murine myotubes and inhibition by eicosapentaenoic acid
5. Studies on the anti-obesity activity of zinc-[alpha]2-glycoprotein in the rat
6. Studies on the antiobesity effect of zinc-[alpha]2-glycoprotein in the ob/ob mouse
7. Antiobesity activity of zinc-α2-glycoprotein in ob/ob mice: T1:OS5.2
8. Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue
9. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin–proteasome proteolytic pathway
10. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
11. Cancer cachexia
12. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor
13. Characteristics of patients expressing a novel cancer cachectic factor
14. Prostaglandins and Metastasis
15. Cyclic AMP and Prostaglandins
16. Alterations in Intracellular Cyclic AMP as a Potential Form of Anti-Tumour Chemotherapy
17. Cyclic AMP and Prostaglandins
18. Effects of Eicosapentaenoic Acid on Tumour Growth and Cachexia in Mouse Colon Cancer1
19. 3 Role of Intracellular Mediators in Hormonal Mechanisms
20. Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle
21. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF)
22. Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat
23. Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse
24. The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate
25. Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
26. Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy
27. Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients
28. Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase
29. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice
30. Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
31. Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
32. Angiotensin II directly induces muscle protein catabolism through the ubiquitin–proteasome proteolytic pathway and may play a role in cancer cachexia
33. The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia
34. NF-κB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin–proteasome system in skeletal muscle
35. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation
36. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice
37. Role of protein kinase C and NF-κB in proteolysis-inducing factor-induced proteasome expression in C2C12 myotubes
38. Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage
39. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes
40. Increased expression of the ubiquitin – proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB
41. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin–proteasome pathway
42. Weight Loss in Tumour-Bearing Mice Is Not Associated with Changes in Resistin Gene Expression in White Adipose Tissue
43. Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo
44. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor
45. Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor
46. Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor
47. Mechanisms of Tissue Catabolism and Reversal in Cancer1
48. Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF)
49. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)
50. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.